Leflunomide in Combination With Decitabine for Treatment of Relapsed or Refractory Myelodysplastic Syndromes
for
Myelodysplastic Syndromes
Location: Morgantown WV
Sponsor: West Virginia University
Sex: All
Age: 18+
Code: NCT06923488
Phase1, Phase2, Recruiting
Study of Individuals and Families With Aberrations in DDX41 or Similar Cancer Predisposition Variants
for
Germline Mutation, Myelodysplastic Syndromes,
Location: Bethesda MD
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 0 - 70+
Code: NCT07019155
Recruiting
Collection of Blood, Bone Marrow, Skin, Saliva, and Stool Samples From Healthy Volunteers Used for Comparative Analysis of Myeloid Malignancies
for
Myelodysplastic Syndromes
Location: Bethesda MD
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18 - 70+
Code: NCT05588154
Recruiting
Ivosidenib (IVO) Monotherapy and Azacitidine (AZA) Monotherapy in Patients With Hypomethylating Agent (HMA) Naive Myelodysplastic Syndromes (MDS) With an IDH1 Mutation
Location: Boston MA, New York NY, Chapel Hill NC, Columbus OH,
Sponsor: Institut de Recherches Internationales Servier
Sex: All
Age: 18+
Code: NCT06465953
Phase3, Recruiting
A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation
for
AML (Acute Myelogenous Leukemia), Acute Lymphoid Leukemia (ALL),
Location: Boston MA, New York NY, Charlottesville VA,
Sponsor: Center for International Blood and Marrow Transplant Research
Sex: All
Age: 18 - 66
Code: NCT06859424
Phase2, Recruiting
Interested in new myelodysplastic syndromes trials?
Get alerts for new trials in your area by subscribing now
Chemotherapy (Decitabine in Combination With FLAG-Ida) and Total-Body Irradiation Followed by Donor Stem Cell Transplant for the Treatment of Adults With Myeloid Malignancies at High Risk of Relapse
Phase I/II Study of CAR.70- Engineered IL15-transduced Cord Blood-derived NK Cells in Conjunction With Lymphodepleting Chemotherapy for the Management of Relapse/Refractory Hematological Malignances
for
B-Cell Lymphoma, Myelodysplastic Syndromes (MDS),
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: All
Age: 12 - 70+
Code: NCT05092451
Phase1, Phase2, Recruiting
Study to Evaluate the Pharmacokinetics and Safety of Oral Decitabine and Cedazuridine in Cancer Patients With Renal Impairment
for
Acute Myeloid Leukemia, Myelodysplastic Syndromes
Location: Houston TX
Sponsor: Taiho Oncology, Inc.
Sex: All
Age: 18+
Code: NCT04953897
Phase1, Recruiting
Study to Evaluate the Pharmacokinetics and Safety of Oral Decitabine and Cedazuridine in Cancer Patients With Hepatic Impairment
for
Acute Myeloid Leukemia, Myelodysplastic Syndromes
Location: Houston TX
Sponsor: Taiho Oncology, Inc.
Sex: All
Age: 18+
Code: NCT04953910
Phase1, Recruiting
A Study to Compare Elritercept With Epoetin Alfa to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions
for
Myelodysplastic Syndrome, Anemia
Location: Tamarac FL, Atlanta GA, Nashville TN, Skokie IL,
Sponsor: Takeda
Sex: All
Age: 18+
Code: NCT07422480
Phase3, Recruiting
ICP-248 in Combination With Azacitidine for the Treatment in Patients With Myeloid Malignancies